DARCIE RICHARDSON: Open Payments
NPI 1689131807 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 15 payments from 9 companies in 2025. Trend: 2023 $64 · 2024 $581 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $108 |
| Incyte Corporation | 2 | $44 |
| Gilead Sciences, Inc. | 2 | $40 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Stemline Therapeutics Inc. | 1 | $26 |
| TerSera Therapeutics LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Tempus AI, Inc | 1 | $20 |
Products named: Enhertu, MONJUVI, IMFINZI, Trodelvy, CALQUENCE, Orserdu, Zoladex, Vyloy.
Industry payments across OH — which companies pay providers there.
